Medications
Study: Pembrolizumab combined with soluble EphB4-HSA shows promise in HPV-negative HNSCC
A new research paper published in Oncotarget is titled "Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma."
Jul 22, 2024
0
0